Brief: Idera Pharmaceuticals Announces Name Change To Aceragen, Inc. And Provides Near-Term Strategic Outlook

Aceragen

17/01/2023 14:52

Jan 17 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS ANNOUNCES NAME CHANGE TO ACERAGEN,
INC.
AND PROVIDES NEAR-TERM STRATEGIC OUTLOOK
    * IDERA PHARMACEUTICALS ANNOUNCES NAME CHANGE TO ACERAGEN,
INC.
AND PROVIDES NEAR-TERM STRATEGIC OUTLOOK
    * IDERA PHARMACEUTICALS INC - PROJECTED CASH AVAILABLE IS
EXPECTED
TO PROVIDE COMPANY WITH CAPITAL RUNWAY INTO Q3'2023
    * IDERA PHARMACEUTICALS INC - BOARD OF DIRECTORS HAS
APPROVED
REVERSE STOCK SPLIT AT A RATIO OF 1-FOR-17 SHARES
    * IDERA PHARMACEUTICALS INC - NASDAQ HAS ISSUED AN APPROVAL
LETTER
CONFIRMING ACERAGEN'S LISTING

Source text for Eikon:  ID:nGNX6Z8X2t 
Further company coverage:  IDRA.O